Farther Finance Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 16,236 shares of IOVA stock, worth $32,634. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,236
Previous 15,705
3.38%
Holding current value
$32,634
Previous $51 Million
45.29%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IOVA
# of Institutions
329Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$55.8 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$49.1 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$42.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$25.6 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$22.2 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $317M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...